| Antibody evasion by SARS-CoV-2 Omicron subvariants BA. 2.12. 1, BA. 4 and BA. 5 Q Wang, Y Guo, S Iketani, MS Nair, Z Li, H Mohri, M Wang, J Yu, ... Nature 608 (7923), 603-608, 2022 | 756 | 2022 |
| Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals RI Connor, H Mohri, Y Cao, DD Ho Journal of virology 67 (4), 1772-1777, 1993 | 594 | 1993 |
| Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy H Mohri, AS Perelson, K Tung, RM Ribeiro, B Ramratnam, M Markowitz, ... The Journal of experimental medicine 194 (9), 1277-1288, 2001 | 485 | 2001 |
| Rapid turnover of T lymphocytes in SIV-infected rhesus macaques H Mohri, S Bonhoeffer, S Monard, AS Perelson, DD Ho Science 279 (5354), 1223-1227, 1998 | 424 | 1998 |
| Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection S Mehandru, MA Poles, K Tenner-Racz, P Jean-Pierre, V Manuelli, ... PLoS medicine 3 (12), e484, 2006 | 420 | 2006 |
| Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir S Iketani, H Mohri, B Culbertson, SJ Hong, Y Duan, MI Luck, ... Nature 613 (7944), 558-564, 2023 | 310 | 2023 |
| Mechanisms of Gastrointestinal CD4+ T-Cell Depletion during Acuteand Early Human Immunodeficiency Virus Type 1 Infection S Mehandru, MA Poles, K Tenner-Racz, V Manuelli, P Jean-Pierre, ... Journal of virology 81 (2), 599-612, 2007 | 293 | 2007 |
| In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: Why are CD4+ but not CD8+ T cells depleted? RM Ribeiro, H Mohri, DD Ho, AS Perelson Proceedings of the National Academy of Sciences 99 (24), 15572-15577, 2002 | 278 | 2002 |
| Long-acting integrase inhibitor protects macaques from intrarectal simian/human immunodeficiency virus CD Andrews, WR Spreen, H Mohri, L Moss, S Ford, A Gettie, ... Science 343 (6175), 1151-1154, 2014 | 226 | 2014 |
| Tracking the prevalence of transmitted antiretroviral drug-resistant HIV-1: a decade of experience A Shet, L Berry, H Mohri, S Mehandru, C Chung, A Kim, P Jean-Pierre, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 41 (4), 439-446, 2006 | 224 | 2006 |
| Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report M Markowitz, H Mohri, S Mehandru, A Shet, L Berry, R Kalyanaraman, ... The Lancet 365 (9464), 1031-1038, 2005 | 214 | 2005 |
| A novel and expanding SARS-CoV-2 variant, B. 1.526, identified in New York MK Annavajhala, H Mohri, P Wang, M Nair, JE Zucker, Z Sheng, ... MedRxiv, 2021.02. 23.21252259, 2021 | 171* | 2021 |
| A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge CD Andrews, YL Yueh, WR Spreen, L St. Bernard, M Boente-Carrera, ... Science translational medicine 7 (270), 270ra4-270ra4, 2015 | 156 | 2015 |
| Adjunctive passive immunotherapy in human immunodeficiency virus type 1-infected individuals treated with antiviral therapy during acute and early infection S Mehandru, B Vcelar, T Wrin, G Stiegler, B Joos, H Mohri, D Boden, ... Journal of virology 81 (20), 11016-11031, 2007 | 156 | 2007 |
| Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection TH Evering, S Mehandru, P Racz, K Tenner-Racz, MA Poles, A Figueroa, ... PLoS pathogens 8 (2), e1002506, 2012 | 152 | 2012 |
| Turnover rates of B cells, T cells, and NK cells in simian immunodeficiency virus-infected and uninfected rhesus macaques RJ De Boer, H Mohri, DD Ho, AS Perelson The Journal of Immunology 170 (5), 2479-2487, 2003 | 143 | 2003 |
| Quantitation of zidovudine-resistant human immunodeficiency virus type 1 in the blood of treated and untreated patients. H Mohri, MK Singh, WT Ching, DD Ho Proceedings of the National Academy of Sciences 90 (1), 25-29, 1993 | 123 | 1993 |
| Quantification of cell turnover kinetics using 5-bromo-2′-deoxyuridine1 S Bonhoeffer, H Mohri, D Ho, AS Perelson The Journal of Immunology 164 (10), 5049-5054, 2000 | 114 | 2000 |
| Emergence and expansion of SARS-CoV-2 B. 1.526 after identification in New York MK Annavajhala, H Mohri, P Wang, M Nair, JE Zucker, Z Sheng, ... Nature 597 (7878), 703-708, 2021 | 103 | 2021 |
| Rebound of SARS-CoV-2 infection after nirmatrelvir–ritonavir treatment ME Charness, K Gupta, G Stack, J Strymish, E Adams, DC Lindy, H Mohri, ... New England Journal of Medicine 387 (11), 1045-1047, 2022 | 102 | 2022 |
